Special Diets & Allergies

Celiac/gluten‑free, low FODMAP, diabetes‑friendly, and allergen avoidance plans.

  • 4 Tracked terms
  • Last 30 days Feed window
Search within this topic Ask AI about this topic All topics

What this topic collects on

An article joins this feed when it matches these terms. Each one is also a search of its own.

Latest in Special Diets & Allergies


dearmedia.com > food-allergy-diagnosis

Dating, Dining Out, and Traveling with Food Allergies

9+ hour, 52+ min ago   (867+ words) Food is at the center of so many everyday moments—date nights, family celebrations, vacations, and dinners with friends. For the estimated 33 million people in the U.S. living with food allergies, those same moments can require extra planning, vigilance, and…...


dailyutahchronicle.com > 10/13/2026 > gluten-free-community-explores-safe-foods-at-annual-gluten-free-expo

Gluten-free community explores safe foods at annual gluten-free expo

12+ hour, 16+ min ago   (344+ words) The tenth annual Gluten Free World Expo came to the Mountain America Exposition Center on September 25 and 26. A variety of vendors and organizations offered samples and sold their unique products. Shannon LeMmon, member of the Gluten Intolerance Group of Utah…...


geneonline.com > first-tracks-biotherapeutics-releases-initial-study-data-on-cd122-targeting-drug-for-celiac-disease

First Tracks Biotherapeutics Releases Initial Study Data on CD122-Targeting Drug for Celiac Disease

1+ day, 3+ hour ago   (281+ words) First Tracks Biotherapeutics released initial study data on Monday regarding a new drug candidate designed to target the CD122 protein for the treatment of celiac disease. Analysts noted that the findings suggest the drug may possess the potential to treat multiple…...


markets.businessinsider.com > news > stocks > first-tracks-biotherapeutics-announces-positive-top-line-results-for-anb033-in-gluten-challenge-study-in-celiac-disease-1036616208

First Tracks Biotherapeutics Announces Positive Top-Line Results for ANB033 in Gluten-Challenge Study in Celiac Disease

1+ day, 2+ hour ago   (400+ words) ANB033 demonstrated a statistically significant difference compared to placebo across key histologic endpoints, including least squares (LS) mean change in villus height-to-crypt depth (Vh:Cd) ratio, intraepithelial lymphocyte (IEL) density, and VCIEL composite scale, as well as symptom endpoints using the Celiac…...


biopharmadive.com > news > first-tracks-celiac-study-results-cd122 > 832726

First Tracks climbs on ‘impressive’ celiac study data

1+ day, 7+ hour ago   (476+ words) The company reported positive early-stage data for its celiac drug that has been deemed to have “pipeline-in-a-product potential” by analysts. Celiac disease is an immune disorder in which consuming gluten causes the body to mistakenly attack the small intestine. Over…...


quiverquant.com > news > First+Tracks+Biotherapeutics+to+Host+Investor+Call+and+Webcast+on+Top-Line+Phase+1b+ANB033+Celiac+Disease+Data

First Tracks Biotherapeutics to Host Investor Call and Webcast on Top-Line Phase 1b ANB033 Celiac Disease Data

2+ day, 8+ hour ago   (167+ words) First Tracks Biotherapeutics will discuss top-line data from its celiac disease trial of ANB033 on October 12, 2026. ANB033 is a CD122 antagonist being developed for the treatment of celiac disease and eosinophilic esophagitis. The investor call is scheduled for Monday, Oct. 12, 2026, at 8:30am ET/5:30am PT....


themontclairgirl.com > gluten-free-restaurants-montclair-nj

Restaurants with Gluten-Free Options in Montclair

4+ day, 7+ hour ago   (411+ words) You may think a dish or a food item is gluten-free; however, if something like French fries, which come from naturally gluten-free potatoes, share the same fryer as a non-GF food such as chicken fingers, the French fries can now…...


bioengineer.org > spirulinas-blue-pigment-protein-can-trigger-allergy-but-digestion-weakens-its-grip

Spirulina’s Blue Pigment Protein Can Trigger Allergy, but Digestion Weakens Its Grip

4+ day, 2+ hour ago   (47+ words) A University of Parma study shows that Spirulina's major pigment-protein C-phycocyanin binds IgE from sensitized patients but loses much of its allergenic reactivity after simulated gastrointestinal digestion. News Source: Alan Morgan. (October 9, 2026). Spirulina’s Blue Pigment Protein Can Trigger Allergy, but…...


foodinstitute.com > focus > goldfish-goes-gluten-free-amid-major-undertaking

Goldfish Goes Gluten-Free Amid Major Undertaking

4+ day, 17+ hour ago   (425+ words) Tess Owings | August 25, 2026 Goldfish is now offering a gluten-free option for its popular orange crackers, and gluten-intolerant consumers everywhere are rejoicing. “We’ve heard from many families who love Goldfish but haven’t always been able to enjoy them together, and that…...


mugglehead.com > argenx-fb102-phase2-celiac-endpoint

argenx reports Phase 2 FB102 celiac trial met primary endpoint

5+ day, 22+ hour ago   (736+ words) The biopsy measure improved against placebo after a gluten challenge, with p=0.0176; argenx plans Phase 3 development. A biopsy-based endpoint was met in a Phase 2 celiac study on Thursday as argenx SE EBRARGX NASDAQARGX said its FB102 antibody beat placebo following a…...